New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 18, 2012
10:00 EDTEIX, SWK, QUAD, STJ, PJC, SYK, SKUL, RDS.A, DB, ABT, POT, CMA, HAL, CSXOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Abbott (ABT) downgraded to Market Perform from Outperform at Raymond James... CSX (CSX) downgraded to Hold from Buy at Deutsche Bank... Comerica (CMA) downgraded to Neutral from Buy at Sterne Agee... Deutsche Bank (DB) downgraded to Underweight from Neutral at JPMorgan... Halliburton (HAL) downgraded to Equal Weight from Overweight at Stephens... Potash (POT) downgraded to Sector Perform from Outperform at RBC Capital... Royal Dutch Shell (RDS.A) downgraded to Sell from Neutral at Goldman... Skullcandy (SKUL) downgraded to Market Perform from Strong Buy at Raymond James... St. Jude Medical (STJ) downgraded to Hold from Buy at Canaccord...Stanley Black & Decker (SWK) downgraded to Market Perform from Outperform at Raymond James... Stryker (SYK) downgraded to Perform from Outperform at Oppenheimer... Quad/Graphics (QUAD) downgraded to Underperform at Sector Perform at RBC Capital... Edison International (EIX) downgraded to Neutral from Buy at Citigroup... Piper Jaffray (PJC) downgraded to Hold from Buy at Sandler O'Neill.
News For A;SKUL;STJ;SWK;SYK;QUAD;EIX;PJC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
January 28, 2015
08:31 EDTQUADCourier board says R.R. Donnelley proposal could be 'superior'
Courier Corporation (CRRC) announced that its Board of Directors has reasonably determined in good faith, after consultation with its independent legal and financial advisors, that the non-binding, unsolicited proposal from R.R. Donnelley & Sons Company (RRD) to acquire the Company for $23.00 per share in cash or RR Donnelley common stock is reasonably likely to result in a “Superior Proposal” as defined in Courier’s merger agreement with Quad/Graphics, Inc. (QUAD). As previously announced, the RR Donnelly proposal is subject to proration in the event that Courier shareholders elect to receive more than approximately 49% cash or more than approximately 51% stock, and is subject to, among other things, various closing conditions, Courier shareholder approval and regulatory approvals. Under the Quad/Graphics agreement, the Courier Board’s determination allows Courier to provide information to and conduct discussions and negotiations with RR Donnelley, but does not allow Courier to terminate its agreement with Quad/Graphics or enter into any other agreement with RR Donnelley. Courier’s Board has not determined that RR Donnelley’s proposal in fact constitutes a Superior Proposal under the existing merger agreement with Quad/Graphics and has not changed its recommendation in support of the merger with Quad/Graphics. There can be no assurance that the discussions with RR Donnelley will result in the Courier Board’s determination that the RR Donnelley proposal is a Superior Proposal or the consummation of a transaction that is superior to the pending transaction with Quad/Graphics or that the terms of any new transaction will be the same as those reflected in RR Donnelley’s proposal. Courier will have no further comment on RR Donnelley’s proposal until the Board has completed discussions and/or negotiations with RR Donnelley.
07:18 EDTSTJSt. Jude Medical sees Q1 adjusted EPS 90c-92c, consensus 97c
Sees Q1 revenue up 2%-4% on a constant currency basis with currency negatively impacting first quarter revenue by approximately $85M-$100M, consensus $1.37B.
07:18 EDTSTJSt. Jude Medical sees FY15 adjusted EPS $3.95-$4.00, consensus $4.13
Subscribe for More Information
07:16 EDTSTJSt. Jude Medical reports Q4 CRM sales $685M
Subscribe for More Information
07:15 EDTSTJSt. Jude Medical reports Q4 adjusted EPS $1.03, consensus $1.03
Subscribe for More Information
06:43 EDTSYKStryker still looking to make acquisitions, Reuters reports
Subscribe for More Information
January 27, 2015
16:34 EDTSTJSt. Jude Medical announces FDA approval of FlexAbility Ablation Catheter
Subscribe for More Information
16:19 EDTSYKStryker sees Q1 adjusted EPS $1.05-$1.10, consensus $1.17
Styrker said, if foreign currency exchange rates hold near current levels, the company expects sales in the first quarter and full year of 2015 to be negatively impacted by approximately 3% to 4% and adjusted diluted net earnings per share to be negatively impacted by approximately 8c and 30c in the first quarter and the full year, respectively.
16:18 EDTSYKStryker sees FY15 adjusted EPS $4.90-$5.10, consensus $5.14
Sees FY15 constant currency sales growth in the range of 5.5%-7.0%, including organic sales growth in the range of 4.5%-6.0%. Consensus $10.11B.
16:06 EDTSYKStryker reports Q4 adjusted EPS $1.44, consensus $1.45
Subscribe for More Information
15:35 EDTSTJNotable companies reporting before tomorrow's open
Subscribe for More Information
15:35 EDTSYKNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Apple (AAPL), consensus $2.60; AT&T (T), consensus 55c; Amgen (AMGN), consensus $2.05; Yahoo (YHOO), consensus 29c; ACE (ACE), consensus $2.29; Stryker (SYK), consensus $1.45; Western Digital (WDC), consensus $2.10; Electronic Arts (EA), consensus 92c; Juniper (JNPR), consensus 31c; Total System Services (TSS), consensus 53c; Freescale Semiconductor (FSL), consensus 33c; Amdocs (DOX), consensus 81c; VMware (VMW), consensus $1.07; International Game Technology (IGT), consensus 25c; United States Steel (X), consensus 87c; Cytec (CYT), consensus 61c.
11:06 EDTAAgilent announces China FDA approval of SureScan Dx microarray scanner
Subscribe for More Information
08:32 EDTQUADCourier board has not changed recommendation in support of Quad/Graphics merger
08:31 EDTQUADCourier confirms receipt of unsolicited proposal from R.R. Donnelley
Subscribe for More Information
January 26, 2015
10:00 EDTPJCOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: American Axle (AXL) upgraded to Overweight from Neutral at JPMorgan... Bed Bath & Beyond (BBBY) upgraded to Outperform from Perform at Oppenheimer... DRDGOLD (DRD) upgraded to Neutral from Underweight at JPMorgan... DealerTrack (TRAK) upgraded to Buy from Hold at Stifel... DreamWorks Animation (DWA) upgraded to Buy from Neutral at B. Riley... First Niagara (FNFG) upgraded to Buy from Hold at Jefferies... Fortinet (FTNT) upgraded to Buy from Neutral at Citigroup... Garmin (GRMN) upgraded at RBC Capital... Harmony Gold (HMY) upgraded to Overweight from Neutral at JPMorgan... Invesco (IVZ) upgraded to Positive from Neutral at Susquehanna... Kansas City Southern (KSU) upgraded at Raymond James... McDonald's (MCD) upgraded to Overweight from Equal Weight at Stephens... Melco Crown (MPEL) upgraded to Buy from Hold at Union Gaming... Monro Muffler (MNRO) upgraded to Neutral from Reduce at SunTrust... Pier 1 Imports (PIR) upgraded to Outperform from Perform at Oppenheimer... Piper Jaffray (PJC) upgraded to Neutral from Underperform at Macquarie... Randgold (GOLD) upgraded to Overweight from Neutral at JPMorgan... Rockwell Collins (COL) upgraded to Buy from Hold at Argus... Telefonica (TEF) upgraded to Neutral from Underperform at BofA/Merrill... Triumph Group (TGI) upgraded at RBC Capital... Unilever (UL) upgraded to Buy from Underperform at BofA/Merrill... WWE (WWE) upgraded to Neutral from Underperform at Macquarie.
07:26 EDTPJCPiper Jaffray upgraded to Neutral from Underperform at Macquarie
Subscribe for More Information
07:17 EDTSTJSociety of Thoracic Surgeons to hold annual meeting
51st Annual Meeting of STS is being held in San Diego, California on January 24-28.
January 21, 2015
08:51 EDTPJCArena Pharma sells 21M shares to Leucadia's Jefferies and Piper Jaffray
Arena Pharmaceuticals (ARNA) has sold 21M shares of common stock to Jefferies, a subsidiary of Leucadia (LUK) and to Piper Jaffray (PJC) as underwriters for its previously announced public offering. The offering is expected to close on or about January 26. In addition, Arena has granted the underwriters a 30-day option to purchase up to an aggregate of 3M additional shares of common stock. Arena anticipates using the net proceeds from the offering for the clinical and preclinical development of drug candidates, for discovery research for new drug candidates, and for general corporate purposes.
January 16, 2015
08:31 EDTQUADQuad/Graphics to acquire Courier in deal valued at approx. $260M
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use